The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction

Table 4 Adipokine status indicators in patients with myocardial infarction with or without visceral obesity during hospitalization

Variable	Control (n = 30)	Patients with visceral obesity, n = 64		Patients without visceral obesity, n = 30
	Control (n = 30)	1st day	12th day	1st day	12th day
	1	2	3	4	5
Leptin, ng/ml	5.1 (4.6;5.3)	29.3 (15.0;41.4) p_1–2 = 0.01	20.07 (14.4;30.1) p_1–3 = 0.01 p_2–3 = 0.001	14.6 (9.1;22.0) p_1–4 = 0.002 p_2–4 = 0.001	9.7 (5.8;10.7) p_1–5 = 0.005 p_3–5 = 0.004 p_4–5 = 0.003
Adiponectin, mg/ml	13.3(9.4;14.5)	7.7 (5.4;10.6) p_1–2 = 0.01	8.3 (5,3;11.2) p_1–3 = 0.02 p_2–3 = 0.04	9.7 (8.5;13.0) p_1–4 = 0.02	12.3 (8.7;16.3) p_1–5 = 0.04 p_3–5 = 0.02 p_4–5 = 0.04

Data in the table are presented as median (Me) and 25 and 75 % quartiles (Q1;Q3)
p value for differences between groups (p < 0.05)

ISSN: 1758-5996